Pharmafile Logo

B2B sales

Gilead Sciences

Gilead’s Biktarvy gets European approval, setting up battle with GSK

The drug could offset Gilead's disappointing hep C franchise

- PMLiVE

Plasticell and London’s gene therapy pioneers to tackle manufacturing conundrum

New funding will help London build on its gene therapy expertise

- PMLiVE

Diversity and inclusion in the pharma industry

Is there equality in the workplace?

- PMLiVE

Wilmington Healthcare appoints new Commercial Director

Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Binley’s, OnMedica and Wellards, has appointed Sue Plant as Commercial Director for MedTech.

Wilmington Healthcare

- PMLiVE

US approval for first ever cannabis-based medicine

UK company's Epidiolex tipped to be blockbuster

- PMLiVE

Doing more with less: when ‘client-centricity’ matters most

At a time when companies face continued downward pressure on operational expenditure, doing ‘more with less’ is becoming a fact of life

- PMLiVE

Is flexible working the future?

How adopting a flexible approach allows access for senior talent

- PMLiVE

Boehringer beefs up biologics capacity with €230m investment

New facility to focus on analytical and process development and manufacturing of biologics for trials.

- PMLiVE

Lucid’s “spellbinding” performance prompts multiple wins at Communiqué 2018

Its haul included the Communications Consultancy of the Year

- PMLiVE

Johnson and Johnson’s second-in-command announces retirement plans

Sandra Peterson departs at the start of October

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links